February 19, 2009
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Orchid Cellmark Inc. | |
January 13, 2009 Supplemental Correspondence in connection Form 10-K for the Fiscal Year Ended December 31, 2008 | ||
Schedule DEFR 14A for June 5, 2008 | ||
File No. 0-30267 |
Ladies and Gentlemen:
On behalf of Orchid Cellmark Inc. (the “Company”), we hereby acknowledge receipt of your letter dated February 4, 2009 (the “Comment Letter”), which includes a comment by the Staff (the “Staff”) of the Securities and Exchange Commission concerning the Company’s Schedule DEFR 14A for its annual meeting that occurred on June 5, 2008. The Company has begun the process necessary to furnish the Staff with a response to its comment, but requires additional time to coordinate the needed input and analysis of various sources, including the Company’s compensation committee, senior management, legal counsel and certain other employees, to finalize its response.
The Comment Letter requests that the Company respond to the comment by Thursday, February 19, 2009 or tell the Staff the date by when the Company will provide its response. Based on a telephone conversation that we had with Susann Reilly on February 18, 2009, we hereby respectfully request on behalf of the Company an extension for the Company’s response until Thursday, March 19, 2009. Of course, if you have any questions regarding this letter, kindly contact the undersigned at 617-348-1715. We appreciate the Staff’s consideration of this request.
Very truly yours, |
/s/ Daniel T. Kajunski |
Daniel T. Kajunski |
cc: | Securities and Exchange Commission | |
Susann Reilly, Esq. |
Securities and Exchange Commission
February 19, 2009
Page 2 of 2
Orchid Cellmark Inc. Thomas A. Bologna, Chief Executive Officer James F. Smith, President and Chief Financial Officer William J. Thomas, Vice President and General Counsel
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, P.C. John J. Cheney, Esq. |